Design Therapeutics Ownership | Who Owns Design Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Design Therapeutics Ownership Summary

Design Therapeutics is owned by 117.81% institutional investors, 36.45% insiders. Price t rowe associates inc /md/ is the largest institutional shareholder, holding 12.90% of DSGN shares. iShares Russell 2000 ETF is the top mutual fund, with 1.43% of its assets in Design Therapeutics shares.

DSGN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Design Therapeutics	117.81%	36.45%	-54.27%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Biotech Stocks	44.97%	7.82%	47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Price t rowe associates inc /md/	7.29M	12.90%	$705.90M
Durable capital partners lp	3.46M	6.12%	$334.67M
Vanguard group	3.19M	5.65%	$309.29M
Conestoga capital advisors	3.12M	5.52%	$301.76M
Jarislowsky, fraser	2.89M	5.12%	$279.97M
Fiera capital	2.56M	4.53%	$248.02M
Primecap management co/ca/	2.24M	3.96%	$216.78M
Mackenzie financial	2.13M	3.78%	$206.81M
Connor, clark & lunn investment management	2.05M	3.63%	$198.72M
T. rowe price investment management	1.70M	3.00%	$164.35M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Zeno equity partners llp	266.28K	6.86%	$25.79M
Conestoga capital advisors	3.12M	4.52%	$301.76M
Herald investment management	230.00K	3.65%	$22.24M
Summit creek advisors	258.25K	3.43%	$25.01M
Aperture investors	236.27K	3.34%	$22.89M
Durable capital partners lp	3.46M	2.75%	$334.67M
Geneva capital management	1.46M	2.57%	$141.16M
Triasima portfolio management	253.85K	2.25%	$24.58M
Pembroke management	125.98K	2.24%	$16.70M
Minichmacgregor wealth management	79.95K	1.89%	$7.74M

Top Buyers

Holder	Shares	% Assets	Change
Congress asset management co /ma	1.22M	0.85%	1.22M
Norges bank	1.12M	0.02%	1.12M
Ubs asset management americas	690.48K	0.02%	690.48K
Blackrock	566.21K	0.00%	213.67K
William blair investment management	212.81K	0.05%	212.81K

Top Sellers

Holder	Shares	% Assets	Change
Arrowstreet capital, limited partnership	611.83K	0.05%	-633.32K
Jarislowsky, fraser	2.89M	1.70%	-438.99K
T. rowe price investment management	1.70M	0.10%	-379.50K
Price t rowe associates inc /md/	7.29M	0.08%	-313.25K
Goldman sachs group	391.94K	0.01%	-213.09K

New Positions

Holder	Shares	% Assets	Change	Value
Congress asset management co /ma	1.22M	0.85%	1.22M	$118.30M
Norges bank	1.12M	0.02%	1.12M	$108.88M
Ubs asset management americas	690.48K	0.02%	690.48K	$66.87M
William blair investment management	212.81K	0.05%	212.81K	$20.61M
Charles schwab investment management	176.46K	0.00%	176.46K	$17.09M

Sold Out

Holder	Change
Financial gravity asset management	-11.00
Harbour investments	-12.00
Spire wealth management	-18.00
Clarivest asset management	-22.00
Crewe advisors	-50.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	323	6.60%	66,550,531	2.13%	117	869551.63%	186	8.77%	92	-6.12%
Mar 31, 2024	303	5.57%	65,164,649	-1.21%	-	0.00%	171	4.91%	98	7.69%
Dec 31, 2023	287	12.55%	65,959,698	1.06%	117	0.87%	163	42.98%	91	-13.33%
Sep 30, 2023	255	-1.16%	65,268,405	-1.58%	116	0.83%	114	-11.63%	105	12.90%
Jun 30, 2023	258	1.57%	66,314,295	0.22%	118	0.85%	129	-8.51%	93	16.25%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Russell 2000 ETF	809.27K	1.43%	-1.82K
Vanguard Total Stock Mkt Idx Inv	800.90K	1.41%	-
Fidelity Select Biotechnology	726.40K	1.28%	20.50K
Vanguard Institutional Extnd Mkt Idx Tr	399.50K	0.71%	-
Fidelity Small Cap Index	320.41K	0.57%	-4.39K
iShares Russell 2000 Value ETF	292.40K	0.52%	-
State St Russell Sm/Mid Cp® Indx NL Cl C	272.76K	0.48%	-6.50K
Fidelity Extended Market Index	172.25K	0.30%	35.33K
Vanguard Russell 2000 ETF	142.81K	0.25%	-884.00
Schwab US Small-Cap ETF™	141.34K	0.25%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 09, 2024	William Arsani	-	Sell	$3.46M
Mar 22, 2024	Schmid John P.	-	Buy	$33.13K
Mar 25, 2024	Schmid John P.	-	Buy	$66.61K
Mar 25, 2024	Berger Heather A.	-	Buy	$4.87K
Sep 29, 2023	LAPPE RODNEY W	-	Buy	$49.29K

Insider Transactions Trends

Date	Buy	Sell
2024 Q1	3	-
2023 Q4	-	-
2023 Q3	4	-
2023 Q2	-	-
2023 Q1	-	-

DSGN Ownership FAQ

Who Owns Design Therapeutics?

Design Therapeutics shareholders are primarily institutional investors at 117.81%, followed by 36.45% insiders and -54.26% retail investors. The average institutional ownership in Design Therapeutics's industry, Biotech Stocks , is 44.97%, which Design Therapeutics exceeds.

Who owns the most shares of Design Therapeutics?

Design Therapeutics’s largest shareholders are Price t rowe associates inc /md/ (7.29M shares, 12.90%), Durable capital partners lp (3.46M shares, 6.12%), and Vanguard group (3.19M shares, 5.65%). Together, they hold 24.68% of Design Therapeutics’s total shares outstanding.

Does Blackrock own Design Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Design Therapeutics.

Who is Design Therapeutics’s biggest shareholder by percentage of total assets invested?

Zeno equity partners llp is Design Therapeutics’s biggest shareholder by percentage of total assets invested, with 6.86% of its assets in 266.28K Design Therapeutics shares, valued at 25.79M$.

Who is the top mutual fund holder of Design Therapeutics shares?

iShares Russell 2000 ETF is the top mutual fund holder of Design Therapeutics shares, with 1.43% of its total shares outstanding invested in 809.27K Design Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools